Naturemary expands across Canada as pain relief demand grows

Calgary-based naturemary is widening its national footprint as aging demographics, chronic pain and consumer demand for faster, more localized relief reshape Canada’s pain-management market. The company says it is building a broader retail, pharmacy and healthcare-professional network while exploring international expansion.

Why it matters: - Canada’s aging population and rising rates of arthritis, musculoskeletal disorders and menopause-related symptoms are increasing demand for pain-management products. - Employers are absorbing productivity losses tied to chronic or recurring pain, while the healthcare system faces higher economic pressure. - More Canadians are looking for relief that works quickly, fits daily routines and can reduce reliance on systemic medication when appropriate. - naturemary sees that shift as a major opening for consumer health brands that combine science, trust and retail access.

What happened: - naturemary, a Calgary-based consumer health company, said it is expanding its national presence as demand for pain-management solutions continues to grow. - Chief Executive Officer and Founder Sonia Kalra said the company believes a “new pain economy” is emerging. - Kalra said naturemary was created to bridge the gap between pharmaceutical products and traditional natural remedies. - Kapil Kalra, president and co-founder, said the company aims to become a globally recognized Canadian leader in pain relief. - naturemary says its products are now distributed nationally through McKesson Canada. - The company’s products are also available through pharmacy and retail partners including Pharmasave, Lawtons Drugs, Sobeys, Safeway, London Drugs, PharmaChoice and other independent pharmacy groups.

The details: - Sonia Kalra co-founded naturemary with her husband after living with chronic pain associated with Premenstrual Dysphoric Disorder, or PMDD. - Kalra drew on her background in biology and neuroscience to develop a topical pain-relief approach built around plant-derived ingredients and the body’s biological pathways. - naturemary says its products are designed to provide fast, localized relief. - The company is expanding healthcare-professional education programs for pharmacists and physicians. - naturemary is also exploring international opportunities in Asia, the Middle East and other global markets. - The company describes its approach as “A New Pathway to Pain Relief.”

Between the lines: - naturemary is positioning itself as more than a wellness brand and closer to a science-driven consumer health company. - The company’s messaging tracks a broader market shift: buyers want proof of performance, not just a label that says natural or pharmaceutical. - Its growth strategy relies on three things at once: product credibility, healthcare-professional support and broad retail distribution. - The international expansion push suggests naturemary is trying to turn a Canadian category play into a larger export opportunity.

What’s next: - naturemary plans to keep building pharmacy and retail distribution across Canada. - The company is likely to expand education efforts with healthcare professionals as part of adoption efforts. - International market development in Asia, the Middle East and other regions is also underway.

The bottom line: - naturemary is betting that Canada’s pain-management market is ready for a plant-based, science-backed alternative with mainstream retail reach.